Business Description
Founded in 1915 and based in Valby, Denmark, H. Lundbeck A/S is a global pharmaceutical company focused entirely on brain diseases, developing and selling treatments for conditions such as depression, schizophrenia, epilepsy, migraine, and Parkinson's disease across Europe, the United States, and beyond. The company markets a broad portfolio of established medicines while maintaining an active pipeline of new treatments in various stages of clinical testing. Lundbeck also works with external partners, including a collaboration with Contera Pharma to explore a new class of medicines for serious neurological conditions.
